Linezolid Sandoz 600 mg / 300 ml i.v., Infusionslösung

7680657080018 CH-65708 Infusionslösung
Linezolid Sandoz 600 mg / 300 ml i.v., Infusionslösung
Linezolid Sandoz 600 mg / 300 ml i.v., Infusionslösung
Linezolid Sandoz 600 mg / 300 ml i.v., Infusionslösung
1 / 3
google

Article details

Package size
10 x 1
Selling units
10
Measure
Beutel
Galenic form
Infusionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Detailed composition

Substance Quantity Type Category
linezolidum
2.0 MG Substance Wirkstoff (Principe actif)
glucosum monohydricum
48.0 MG Substance HBESI
acidum citricum
- Substance HNIDK
natrii citras dihydricus
- Substance HNIDK
natrii hydroxidum
- Substance HNIDK
acidum hydrochloridum
- Substance HNIDK
aqua ad iniectabile
- Substance HNIDK
natrium
0.38 MG Substance HBESI

Reimbursement information

Public price
CHF 550.70
Specialties list
Yes
Generic
Yes

Reimbursement limitation

SL addition date: 01/01/2017

Authorization holder

Sandoz Pharmaceuticals AG

6343 Risch

Authorization information

Swissmedic authorization number
65708
Drug name
Linezolid Sandoz 600 mg / 300 ml i.v., Infusionslösung
Galenic form
LSPA
ATC Code
J01XX08
Authorization status
Z
Dispensing category
A
First authorization
10/05/2016
Authorization expiration date
31/12/9999
IT Number
08.01.9.
Domain
Human medicine
Field of application
Infektionskrankheiten

Package details

Description (FR)
LINEZOLIDE Sandoz sol perf 600 mg/300ml 10 pce
Description (DE)
LINEZOLID Sandoz Inf Lös 600 mg/300ml 10 Stk
Market launch
10/05/2016
Market withdrawal
03/12/2025
Narcotic (BTM)
No

Original drug

Zyvoxid 20 mg/ml, Granulat zur Herstellung einer Suspension zum Einnehmen
GTIN: 7680555590022
CHF 279.75
View original
Buy us a coffee Explore the data